Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

NORTHWEST BIOTHERAPEUTICS INC

  • Business News
  • May 27, 2026, 17:53 UTC
  • 0
  • 1 comments

Clinical trial NCT06466161: enrollment: not set → 110 participants.

Market reaction Comment Full text

NEUROCRINE BIOSCIENCES INC (NBIX)

  • Business News
  • May 27, 2026, 17:53 UTC
  • 0
  • 1 comments

Clinical trial NCT05226780: enrollment: not set → 8 participants.

Market reaction Comment Full text

MOLECULAR PARTNERS AG (MLLCF)

  • Business News
  • May 27, 2026, 17:53 UTC
  • 0
  • 1 comments

Clinical trial NCT07523997: enrollment: not set → 30 participants.

Market reaction Comment Full text

ELI LILLY & CO (LLY)

  • Business News
  • May 27, 2026, 17:53 UTC
  • 0
  • 1 comments

Clinical trial NCT05469126: enrollment: not set → 26 participants.

Market reaction Comment Full text

ABBVIE INC. (ABBV)

  • Business News
  • May 27, 2026, 17:53 UTC
  • 0
  • 1 comments

Clinical trial NCT05445778: enrollment: not set → 520 participants.

Market reaction Comment Full text

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (TSOI)

  • Business News
  • May 27, 2026, 17:53 UTC
  • 0
  • 1 comments

Clinical trial NCT07608432: enrollment: not set → 90 participants.

Market reaction Comment Full text

NOVARTIS AG (NVSEF)

  • Business News
  • May 27, 2026, 17:53 UTC
  • 0
  • 1 comments

Clinical trial NCT07431177: enrollment: not set → 210 participants.

Market reaction Comment Full text

MERCK & CO., INC. (MRK)

  • Business News
  • May 27, 2026, 17:53 UTC
  • 0
  • 1 comments

Clinical trial NCT06459180: enrollment: not set → 686 participants.

Market reaction Comment Full text

PFIZER INC (PFE)

  • Business News
  • May 27, 2026, 17:53 UTC
  • 0
  • 1 comments

Clinical trial NCT07269301: enrollment: not set → 26 participants.

Market reaction Comment Full text

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (TSOI)

  • Business News
  • May 27, 2026, 17:53 UTC
  • 0
  • 1 comments

Clinical trial NCT06492616: enrollment: not set → 4220 participants.

Market reaction Comment Full text
  • Previous
  • 812
  • 813
  • 814
  • 815
  • 816
  • Next

Search

News categories

  • Technical Exchange News(13024)
  • Event(6229)
  • SEC News(322732)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(181762)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin